Published September 2026
EU Pharma Package
Far-reaching changes to pharmaceutical legislation in the European Union (EU) will soon come into force – which will affect both the research-based pharmaceutical and the generic and biosimilar industries. This video explains what is changing, and the impact of the changes on regulatory and patent-based exclusivity on pharmaceutical products in the EU in the future.